1-9 of 9
Young Woong Won
Close
Sort by
Journal Articles

Understanding Thrombosis and Hemorrhage in Myeloproliferative Neoplasms through a Nationwide Study

Joon Young Hur, Nayeon Choi, Jung Hye Choi, Jiyeong Kim, Young-Woong Won
Journal: Blood
Blood (2023) 142 (Supplement 1): 1274.
https://doi.org/10.1182/blood-2023-185924
Published: 2023
Journal Articles

Current Treatment Patterns and Outcomes in Patients with Peripheral T-Cell Lymphoma: Updated Results of the Nationwide, Multi-Center Prospective Registry Study (CISL 1404)

Hyungwoo Cho, MD, Dok Hyun Yoon, Dong-Yeop Shin, MD PhD, Sung-Soo Yoon, MD PhD, Seok Jin Kim, MD PhD, Young Rok Do, PhDMD, Gyeong-Won Lee, MD PhD, Kwak Jae-Yong, Yong Park, Min Kyoung Kim, MD PhD, Hye Jin Kang, MD PhD, Jun Ho Yi, MD PhD, Kwai Han Yoo, MD, Won Sik Lee, MD PhD, Park Byeong Bae, Jae-Cheol Jo, MD, Hyeon-Seok Eom, MD, Hyo Jung Kim, MD PhD, Jeong Seong Hyun, MD, Young-Woong Won, Byeong Seok Sohn, MD PhD, Jihyun Kwon, MD, Cheolwon Suh, Won Seog Kim, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2844.
https://doi.org/10.1182/blood-2019-129664
Published: 2019
Journal Articles

Characterization of ABL Compound Mutation Using Sanger and Subcloning Sequencing in Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia

Sukjoong Oh, Ki Hoon Kang, Won-Sik Lee, MD PhD, Hyeoung-Joon Kim, Jee Hyun Kong, Yunsuk Choi, MD, Young Rok Do, MD PhD, Jae-Yong Kwak, Sung-Hyun Kim, MD PhD, Jeong-A Kim, Dae Young Zang, MD PhD, Yeung-Chul Mun, MD PhD, Young-Woong Won, Sung-Eun Lee, MD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2864.
https://doi.org/10.1182/blood.V130.Suppl_1.2864.2864
Published: 2017
Journal Articles

The Impact of Early Molecular Response at 3 Months on Long-Term Survival Was Enhanced in the CP CML Patients Treated with Second-Generation Tyrosine Kinase Inhibitors

Sung-Eun Lee, MD, Won-Sik Lee, MD PhD, Hyeoung-Joon Kim, Jee Hyun Kong, Yunsuk Choi, MD, Young Rok Do, MD PhD, Jae-Yong Kwak, Sukjoong Oh, Sung-Hyun Kim, MD PhD, Jeong-A Kim, Dae Young Zang, Yeung-Chul Mun, MD PhD, Young-Woong Won, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2873.
https://doi.org/10.1182/blood.V130.Suppl_1.2873.2873
Published: 2017
Journal Articles

Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Won-Sik Lee, MD PhD, Hye-Young Song, Hyeoung-Joon Kim, Jee Hyun Kong, Young Rok Do, MD PhD, Jae-Yong Kwak, Sukjoong Oh, Sung-Hyun Kim, MD PhD, Jeong-A Kim, Dae Young Zang, MD PhD, Yeung-Chul Mun, MD PhD, Young-Woong Won, Sung-Eun Lee, MD, Yunsuk Choi, MD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1593.
https://doi.org/10.1182/blood.V130.Suppl_1.1593.1593
Published: 2017
Journal Articles

Comparison of Clinical Diagnosis for Hereditary Spherocytosis with Molecular Diagnosis By Multi-Gene Target Sequencing in Korea

Hyoung Soo Choi, MD PhD, Qute Choi, MD PhD, Jung Ah Kim, Kyong Ok Im, MT, Si Nae Park, Yoomi Park, Ju Han Kim, MD PhD, Hee Young Shin, MD PhD, Seon Young Kim, MD PhD, Hyoung Jin Kang, MD PhD, Hoon Kook, MD, Soo-Jeong Kim, MD, Inho Kim, MD PhD, Ji Yoon Kim, MD, Hawk Kim, Kyung Duk Park, MD PhD, Kyung Bae Park, MD PhD, Meerim Park, MD PhD, Sang Kyu Park, MD, Eun Sil Park, MD PhD, Jeong-A Park, MD PhD, Ji Kyoung Park, MD, Hee Jo Baek, MD PhD, Jeong Ho Seo, MD, Ye Jee Shim, MD PhD, Hyo Seop Ahn, MD PhD, Keon Hee Yoo, MD PhD, Hoi Soo Yoon, MD PhD, Kun Soo Lee, MD PhD, Kwang Chul Lee, MD PhD, Jae Min Lee, MD, Mee Jeong Lee, MD PhD, Sun Ah Lee, MD, Jun Ah Lee, MD PhD, Jae Hee Lee, MD, Ji Won Lee, MD PhD, Young-Woong Won, MD, Young Tak Lim, MD, Hyun Joo Jung, MD, Hee Won Cheuh, MD PhD, Eun Jin Choi, MD PhD, Hye Lim Jung, MD PhD, Dong Soon Lee, The Hereditary Hemolytic Anemia Working Party of the Korean Society of Hematology
Journal: Blood
Blood (2016) 128 (22): 1243.
https://doi.org/10.1182/blood.V128.22.1243.1243
Published: 2016
Journal Articles

Clinical Outcomes in Patients with Diffuse Large B Cell Lymphoma with Partial Responses to First-Line R-CHOP Chemotherapy: Prognostic Value of Secondary IPI Scores and FDG-PET

Hyewon Lee, MD, Yu Ri Kim, Soo-Jeong Kim, MD, Yong Park, MD PhD, Hyeon-Seok Eom, Sung Yong Oh, MD, Hyo Jung Kim, Hye Jin Kang, Won-Sik Lee, Joon Ho Moon, MD, PhD, Young-Woong Won, MD PhD, Myung Hee Chang, Hye In Park, Jin Seok Kim, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4205.
https://doi.org/10.1182/blood.V128.22.4205.4205
Published: 2016
Journal Articles

Safety and Efficacy Of Imatinib In Elderly Patients With Chronic-Phase Chronic Myeloid Leukemia: Analysis Of Outcome For < 60 Years Versus ≥ 60 Years

Young-Woong Won, M.D., Ph.D., DongWook Kim, Sung-Eun Lee, M.D., Soo Young Choi, Soo-Hyun Kim, Eun-Jung Jang
Journal: Blood
Blood (2013) 122 (21): 4039.
https://doi.org/10.1182/blood.V122.21.4039.4039
Published: 2013
Journal Articles

Candidate Pathway Approach of Single Nucleotide Polymorphism On Imatinib Transport/Metabolism Pathway and DNA Repair Enzyme Pathway Associated with Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia.

Jung A. Kim, Dong Hwan Dennis Kim, Young Woong Won, Silvia Park, Hee-Jin Kim, Sun-Hee Kim, Jun Ho Jang, Kihyun Kim, Yeo-Kyeoung Kim, Je-Jung Lee, Hyeoung-Joon Kim, Joon Ho Moon, Sang Kyun Sohn, Chul Won Jung
Journal: Blood
Blood (2009) 114 (22): 3284.
https://doi.org/10.1182/blood.V114.22.3284.3284
Published: 2009